Biotech

All Articles

Biogen, UCB file period 3 lupus win after failing earlier trial

.Biogen as well as UCB's rely on developing right into period 3 astride a broken research study aims...

Aptadir really hopes brand-new RNA preventions may reverse challenging cancers cells

.Italian biotech Aptadir Therapies has introduced along with the promise that its pipe of preclinica...

Wave surfs DMD excellence to regulators' doors, sending out stockpile

.Surge Life Sciences has satisfied its goal in a Duchenne muscle dystrophy (DMD) research study, pos...

Sanofi plucks new CSO from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is returning to the pharma crease, taking...

Achilles splashes tissue therapy plan, braces for layoffs after overlooking 'business feasibility' targets

.Achilles Therapeutics has actually wrecked its own tactic. The British biotech is stopping work on ...

Aligos advertises phase 2 MASH gain, slashing liver excess fat up to 46%

.Aligos Rehabs is proclaiming a midstage gain in metabolic-dysfunction associated steatohepatitis (M...

Basilea scores $268M BARDA backing for antifungals, antibiotics

.Basilea Pharmaceutica's work creating new antifungals has obtained a notable increase from the unit...

Capricor offers Europe civil rights to late-stage DMD treatment for $35M

.Possessing currently gathered up the united state civil rights to Capricor Therapies' late-stage Du...

FDA junks adcomm for Applied's unusual condition medication

.After pushing back the choice meeting for Applied Therapies' metabolic condition medicine govoresta...

Novo inks $600M NanoVation offer to study hereditary medicines ex-liver

.Novo Nordisk is continuing its own press right into genetic medications, accepting compensate NanoV...